about
A molecular marker of artemisinin-resistant Plasmodium falciparum malariaPlasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy peopleMultiple independent introductions of Plasmodium falciparum in South AmericaThe global distribution of the Duffy blood groupIdentification and Characterization of Two Novel RNA Viruses from Anopheles gambiae Species Complex MosquitoesPlasmodium falciparum susceptibility to antimalarial drugs: global data issued from the Pasteur Institutes international networkGlobal analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinineReview of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop reportPlasmodium falciparum Na+/H+ Exchanger (pfnhe-1) Genetic Polymorphism in Indian Ocean Malaria-Endemic AreasLow-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, AngolaChloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in MadagascarWhole genome sequencing of field isolates provides robust characterization of genetic diversity in Plasmodium vivaxFocused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, CambodiaInjections, cocktails and diviners: therapeutic flexibility in the context of malaria elimination and drug resistance in Northeast CambodiaPlasmodium vivax Diversity and Population Structure across Four ContinentsMapping the aetiology of non-malarial febrile illness in Southeast Asia through a systematic review--terra incognita impairing treatment policiesPlasmodium knowlesi Infection in Humans, Cambodia, 2007–2010Plasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataAssessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials.Epidemiological situation of malaria in Madagascar: baseline data for monitoring the impact of malaria control programmes using serological markers.OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic.The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.Heritability of the human infectious reservoir of malaria parasitesAssociation of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from AfricaOrigins of the recent emergence of Plasmodium falciparum pyrimethamine resistance alleles in Madagascar.Plasmodium falciparum founder populations in western Cambodia have reduced artemisinin sensitivity in vitro.Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screeningPolymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Spatial clustering and risk factors of malaria infections in Ratanakiri Province, Cambodia.Effects of mefloquine use on Plasmodium vivax multidrug resistancePlasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study.Extrapulmonary and pulmonary tuberculosis in antananarivo (madagascar): high clustering rate in female patients.In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compoundField trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013Reduced polymorphism in the Kelch propeller domain in Plasmodium vivax isolates from Cambodia.Immunohematological reference ranges for adults from the Central African Republic
P50
Q22061872-FEC4CDD7-C871-4857-974D-547DFD58A54CQ24600330-C9B5CA57-22DA-416A-8304-CBF4D4C0A213Q24609104-77FFED7B-121D-4846-B8BE-E5A086FF08D8Q24620738-9002141D-40FA-455B-956F-6037F9E3AFA1Q24701803-B3637359-4E87-47F3-9DD0-95ECA4609439Q26860875-A24CF651-EBB8-416D-8BB6-BB5928AD0809Q27012884-05280124-5C13-4D97-BFD5-192DE27D5C4FQ27024922-5AF94895-291D-4A75-B8DC-432FB072F921Q27861961-E139D4A0-BCCF-456C-8014-8122C4802284Q28125937-A9600A1C-6141-4ECD-AC23-2D8EC0DCA679Q28475757-C54BF4B2-539A-4432-B57C-0EE818D4F2DBQ28483522-328BF701-CF7F-4F37-91C6-72DA84A5639DQ28484164-9DFD4FF6-72EA-42E9-98B4-A6B2E253E5D5Q28534978-ED90357D-7961-4B88-9C78-91C7AFDB3622Q28545982-08FF0CB2-29FE-49DD-A3A3-9B3CD7C55E25Q28728012-D1DAFD6B-1D32-40FB-AF4C-4C8E6EB0D7E8Q29028776-A94A9C91-56FA-4406-8CBD-0B608E2C909FQ30240158-C4AC60EB-630F-47DB-9040-50AEF572E93CQ30379780-AD3ED78A-4256-49FC-9CF7-03D2233683A5Q30619647-0DFB8E0B-F6AC-4F07-A3C7-9ECAC9FA29CBQ30936416-510584F1-A8F6-4C52-8171-B130BE086C98Q31151729-A2B5DB41-19F7-4882-9911-E2F051B70374Q33431658-6784DFCE-CA91-409F-AF9A-99354603CB6CQ33581150-7303CCC5-DCA3-4F17-9BB6-6BC35E02C590Q33607319-B34E91F9-96FE-4FEC-9D6E-9CDCDFC9CE96Q33627561-67865CA8-3113-474D-8063-F6DBE835976BQ33817484-E911F8FB-71C7-41F1-A6B1-077E3C8C44A3Q33876441-C703DF4B-F316-4440-B90F-9966B596387BQ34058328-463D2E64-07F6-43F6-91CD-4FE23AB26B1FQ34099217-EE86BA28-D3D7-4ACF-9EF6-BB240E42112CQ34281680-47C71A77-0D72-4EFA-8D14-A84A41310826Q34308836-F30319F4-336F-42EB-BF2F-AC9CE628CC5BQ34320936-E75BFEC8-D493-4757-B01F-F8FF603DFEC5Q34354821-0FB95782-9DA6-4C88-8A92-75E85BC5EE83Q34437276-9FD580FF-B3BF-4E52-BCB2-863567A7077BQ34709772-0ABA1B0E-7915-4283-8566-B3E3AC272119Q34777088-CFC8F4F3-D882-4CB9-981A-E9253A732C4CQ34891749-50B05E3B-1D0E-4B1E-8150-C6FD72BC3B8BQ34923492-B316FB92-3383-4186-A881-C5F1DA870C1BQ34995895-1948229C-B7FF-47B7-99D0-C7323C0D8F8F
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Didier Ménard
@ast
Didier Ménard
@en
Didier Ménard
@es
Didier Ménard
@fr
Didier Ménard
@nl
Didier Ménard
@sl
type
label
Didier Ménard
@ast
Didier Ménard
@en
Didier Ménard
@es
Didier Ménard
@fr
Didier Ménard
@nl
Didier Ménard
@sl
prefLabel
Didier Ménard
@ast
Didier Ménard
@en
Didier Ménard
@es
Didier Ménard
@fr
Didier Ménard
@nl
Didier Ménard
@sl
P214
P1053
O-3294-2013
P106
P21
P213
0000 0003 5956 2385
P214
P31
P3829
P3835
didier-menard2
P496
0000-0003-1357-4495
P735
P7859
viaf-220281882